Swiss Life Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.6M Sell
421,213
-45,191
-10% -$4.03M 0.18% 98
2026
Q1
$47M Buy
466,404
+94,860
+26% +$7.31M 0.23% 83
2025
Q4
$29.5M Sell
371,544
-213,343
-36% -$16.8M 0.15% 116
2025
Q3
$44.1M Sell
584,887
-3,390
-0.6% -$232K 0.23% 82
2025
Q2
$40.6M Buy
588,277
+1,346
+0.2% +$88.3K 0.24% 82
2025
Q1
$39.8M Buy
586,931
+27,383
+5% +$1.64M 0.29% 72
2024
Q4
$25.1M Buy
559,548
+354,445
+173% +$19.9M 0.19% 98
2024
Q3
$12.9M Sell
205,103
-8,587
-4% -$501K 0.15% 132
2024
Q2
$12.6M Buy
213,690
+12,456
+6% +$779K 0.15% 132
2024
Q1
$16.1M Sell
201,234
-13,598
-6% -$1.04M 0.22% 102
2023
Q4
$17M Buy
214,832
+49,744
+30% +$3.54M 0.2% 112
2023
Q3
$11.5M Buy
165,088
+22,770
+16% +$1.61M 0.18% 130
2023
Q2
$9.84M Sell
142,318
-29,387
-17% -$2.09M 0.15% 177
2023
Q1
$12.8M Buy
171,705
+42,017
+32% +$3.52M 0.19% 123
2022
Q4
$12.1M Sell
129,688
-50,160
-28% -$4.84M 0.2% 132
2022
Q3
$17.1M Sell
179,848
-7,824
-4% -$774K 0.3% 71
2022
Q2
$17.4M Sell
187,672
-21,508
-10% -$2.1M 0.28% 80
2022
Q1
$21.2M Sell
209,180
-16,342
-7% -$1.72M 0.3% 77
2021
Q4
$23.3M Sell
225,522
-2,019
-0.9% -$187K 0.3% 73
2021
Q3
$19.3M Sell
227,541
-37,713
-14% -$3.16M 0.27% 79
2021
Q2
$15.6M Buy
265,254
+50,453
+23% +$4.13M 0.16% 117
2021
Q1
$16.2M Sell
214,801
-8,576
-4% -$625K 0.23% 98
2020
Q4
$15.3M Buy
223,377
+171,559
+331% +$11.2M 0.22% 98
2020
Q3
$3.02M Sell
51,818
-63,316
-55% -$3.94M 0.05% 273
2020
Q2
$7.48M Buy
115,134
+81,810
+245% +$5.15M 0.12% 142
2020
Q1
$1.98M Buy
33,324
+243
+0.7% +$16.2K 0.04% 308
2019
Q4
$2.46M Sell
33,081
-5,208
-14% -$366K 0.05% 305
2019
Q3
$2.42M Sell
38,289
-86,965
-69% -$5.15M 0.03% 312
2019
Q2
$6.82M Buy
125,254
+65,871
+111% +$3.55M 0.08% 160
2019
Q1
$3.2M Sell
59,383
-217,407
-79% -$13.4M 0.04% 217
2018
Q4
$18.1M Sell
276,790
-43,517
-14% -$3.25M 0.37% 91
2018
Q3
$25.2M Sell
320,307
-252,709
-44% -$18.1M 0.34% 82
2018
Q2
$36.9M Buy
573,016
+143,966
+34% +$9.49M 0.55% 47
2018
Q1
$26.7M Buy
429,050
+348,168
+430% +$25M 0.47% 57
2017
Q4
$5.87M Sell
80,882
-1,036
-1% -$75.3K 0.13% 110
2017
Q3
$6.66M Buy
81,918
+18,368
+29% +$1.45M 0.18% 108
2017
Q2
$5.11M Sell
63,550
-7,404
-10% -$585K 0.13% 114
2017
Q1
$5.57M Buy
70,954
+21,996
+45% +$1.76M 0.15% 105
2016
Q4
$3.86M Sell
48,958
-59,432
-55% -$4.81M 0.13% 110
2016
Q3
$9.65M Buy
108,390
+6,423
+6% +$606K 0.33% 70
2016
Q2
$9.76M Buy
101,967
+25,011
+33% +$2.49M 0.4% 70
2016
Q1
$7.98M Buy
76,956
+1,333
+2% +$130K 0.34% 78
2015
Q4
$7.39M Sell
75,623
-3,095
-4% -$303K 0.33% 79
2015
Q3
$7.59M Buy
78,718
+2,175
+3% +$229K 0.37% 73
2015
Q2
$8.03M Buy
76,543
+828
+1% +$84.6K 0.28% 72
2015
Q1
$7.81M Buy
+75,715
New +$7.66M 0.32% 72

Other funds holding CVS

Swiss Life Asset Management's CVS Position: Q2 2026 in Review

Swiss Life Asset Management reduced its CVS Health (CVS) stake by 9.7% in Q2 2026, selling an estimated $4.03M and leaving 421,213 shares worth $43.6M. The position accounts for 0.18% of the portfolio, ranked #98.

Swiss Life Asset Management first reported a position in CVS in Q1 2015 and has held it in 46 quarters since. The position peaked at $47M in Q1 2026. 1,494 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Swiss Life Asset Management held 421,213 shares of CVS Health worth $43.6M as of Q2 2026.
  • Swiss Life Asset Management sold 45,191 CVS Health shares in Q2 2026, an estimated $4.03M.
  • CVS Health made up 0.18% of Swiss Life Asset Management's portfolio in Q2 2026, its #98 holding.
  • Swiss Life Asset Management first reported a position in CVS Health in Q1 2015 and has held it in 46 quarters since.
  • Swiss Life Asset Management's CVS Health position peaked at $47M in Q1 2026.
  • 1,494 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.